BSE Live
Nov 04, 16:01Prev. Close
1325.45
Open Price
1313.00
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 04, 15:50Prev. Close
1326.00
Open Price
1316.80
Bid Price (Qty.)
1324.70 (8)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Emcure Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 36.43 | 27.54 | 29.42 | 36.62 | |
| Diluted EPS (Rs.) | 36.43 | 27.54 | 29.42 | 36.62 | |
| Cash EPS (Rs.) | 57.61 | 46.37 | 45.45 | 52.39 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 234.65 | 172.33 | 146.51 | 116.90 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 234.65 | 172.33 | 146.51 | 116.90 | |
| Revenue from Operations/Share (Rs.) | 416.71 | 367.55 | 330.98 | 323.77 | |
| PBDIT/Share (Rs.) | 81.36 | 71.03 | 67.85 | 77.05 | |
| PBIT/Share (Rs.) | 61.09 | 53.78 | 53.47 | 63.51 | |
| PBT/Share (Rs.) | 51.26 | 40.14 | 41.32 | 53.78 | |
| Net Profit/Share (Rs.) | 37.34 | 29.12 | 31.07 | 38.85 | |
| NP After MI And SOA / Share (Rs.) | 35.96 | 27.50 | 29.42 | 36.62 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 19.52 | 19.32 | 20.49 | 23.79 | |
| PBIT Margin (%) | 14.65 | 14.63 | 16.15 | 19.61 | |
| PBT Margin (%) | 12.30 | 10.92 | 12.48 | 16.60 | |
| Net Profit Margin (%) | 8.95 | 7.92 | 9.38 | 11.99 | |
| NP After MI And SOA Margin (%) | 8.62 | 7.48 | 8.88 | 11.30 | |
| Return on Networth/Equity (%) | 15.32 | 16.87 | 21.27 | 33.31 | |
| Return on Capital Employed (%) | 20.80 | 21.20 | 26.46 | 37.06 | |
| Return on Assets (%) | 8.27 | 6.38 | 7.97 | 10.92 | |
| Total Debt/Equity (X) | 0.16 | 0.71 | 0.88 | 1.05 | |
| Asset Turnover Ratio (%) | 0.98 | 0.92 | 0.94 | 0.00 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 1.71 | 1.33 | 1.27 | 1.15 | |
| Quick Ratio (X) | 0.98 | 0.85 | 0.81 | 0.67 | |
| Inventory Turnover Ratio (X) | 4.57 | 0.92 | 0.81 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 10.89 | 6.79 | 8.19 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 6.69 | 4.56 | 5.98 | |
| Earnings Retention Ratio (%) | 0.00 | 89.11 | 93.21 | 91.81 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 93.31 | 95.44 | 94.02 | |
| Coverage Ratios | |||||
| Interest Coverage Ratios (%) | 8.77 | 5.43 | 5.74 | 7.92 | |
| Interest Coverage Ratios (Post Tax) (%) | 8.77 | 5.43 | 5.74 | 7.92 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 21,089.51 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 2.67 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 13.68 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 2.57 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 89.10 | 93.20 | 91.80 | |
| Price/BV (X) | 4.57 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 2.57 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.03 | 0.00 | 0.00 | 0.00 |
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
17.07.2025
10.07.2025
07.07.2025
07.08.2025
Emcure Pharmace Standalone June 2025 Net Sales at Rs 1,096.57 crore, up 13.01% Y-o-Y
27.05.2025
Emcure Pharmace Consolidated March 2025 Net Sales at Rs 2,116.25 crore, up 19.47% Y-o-Y
23.05.2025
Emcure Pharmace Standalone March 2025 Net Sales at Rs 1,278.19 crore, up 41.62% Y-o-Y
12.02.2025
Emcure Pharmace Standalone December 2024 Net Sales at Rs 1,028.81 crore, up 18.23% Y-o-Y